Skip to content

Clinical trials

Completed Polycythemia Vera trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Status: Completed Country / region: United States Clear all

107 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20013
20028
20031
20043
20059
20068
20078
20086
20093
20106
20115
20126
20132
20145
20154
20171
20181
20191
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Fred Hutchinson Cancer Center10
M.D. Anderson Cancer Center9
Incyte Corporation5
Icahn School of Medicine at Mount Sinai4
Case Comprehensive Cancer Center3
Memorial Sloan Kettering Cancer Center3
National Institutes of Health Clinical Center (CC)3
Wake Forest University Health Sciences3
Alliance for Clinical Trials in Oncology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera107
Primary Myelofibrosis86
Thrombocythemia, Essential81
Myeloproliferative Disorders67
Precursor Cell Lymphoblastic Leukemia-Lymphoma52
Leukemia, Myeloid, Acute51
Leukemia, Myelomonocytic, Chronic51
Leukemia, Lymphocytic, Chronic, B-Cell50
Multiple Myeloma44
Leukemia42

Trials

Showing 1 to 25 of 107. Each trial links to its page on Pharma Observatory.

7 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.